SEC Info - Abvc Biopharma, Inc. - ‘8-K’ for 9/12/22

SEC Info℠

Home

Help

Please Sign In

Abvc Biopharma, Inc. – ‘8-K’ for 9/12/22 – ‘XML’

On: Tuesday, 9/13/22, at 10:47am ET · For: 9/12/22 · Accession #: 1213900-22-55465 · File #: 1-40700

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/13/22  Abvc Biopharma, Inc.              8-K:8,9     9/12/22   12:214K                                   EdgarAgents LLC/FA

Current Report — Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     26K 
 2: EX-99.1     Press Release, Dated September 13, 2022             HTML     16K 
 3: EX-99.2     Shareholder Letter, Dated September 12, 2022        HTML     12K 
 7: R1          Cover                                               HTML     46K 
10: XML         IDEA XML File -- Filing Summary                      XML     12K 
 8: XML         XBRL Instance -- ea165680-8k_abvcbio_htm             XML     15K 
 9: EXCEL       IDEA Workbook of Financial Reports                  XLSX      8K 
 5: EX-101.LAB  XBRL Labels -- abvc-20220912_lab                     XML     96K 
 6: EX-101.PRE  XBRL Presentations -- abvc-20220912_pre              XML     64K 
 4: EX-101.SCH  XBRL Schema -- abvc-20220912                         XSD     13K 
11: JSON        XBRL Instance as JSON Data -- MetaLinks               25±    33K 
12: ZIP         XBRL Zipped Folder -- 0001213900-22-055465-xbrl      Zip     25K

‘XML’ — XBRL Instance — ea165680-8k_abvcbio_htm

This Document is an XBRL XML File.

<?xml version="1.0" encoding="windows-1252"?>

<link:schemaRef xlink:href="abvc-20220912.xsd" xlink:type="simple"/>

</entity>

</period>

</context>

</unit>

<measure> shares </measure>

</unit>

</unitNumerator>

<measure> shares </measure>

</unitDenominator>

</divide>

</unit>

<dei:EntityCentralIndexKey contextRef="From2022-09-12to2022-09-12"> 0001173313 </dei:EntityCentralIndexKey>

<dei:AmendmentFlag contextRef="From2022-09-12to2022-09-12"> false </dei:AmendmentFlag>

<dei:DocumentType contextRef="From2022-09-12to2022-09-12"> 8-K </dei:DocumentType>

<dei:DocumentPeriodEndDate contextRef="From2022-09-12to2022-09-12"> 2022-09-12 </dei:DocumentPeriodEndDate>

<dei:EntityRegistrantName contextRef="From2022-09-12to2022-09-12"> ABVC BIOPHARMA, INC. </dei:EntityRegistrantName>

<dei:EntityIncorporationStateCountryCode contextRef="From2022-09-12to2022-09-12"> NV </dei:EntityIncorporationStateCountryCode>

<dei:EntityFileNumber contextRef="From2022-09-12to2022-09-12"> 333-91436 </dei:EntityFileNumber>

<dei:EntityTaxIdentificationNumber contextRef="From2022-09-12to2022-09-12"> 26-0014658 </dei:EntityTaxIdentificationNumber>

<dei:EntityAddressAddressLine1 contextRef="From2022-09-12to2022-09-12"> 44370 Old Warm Springs Blvd. </dei:EntityAddressAddressLine1>

<dei:EntityAddressCityOrTown contextRef="From2022-09-12to2022-09-12"> Fremont </dei:EntityAddressCityOrTown>

<dei:EntityAddressStateOrProvince contextRef="From2022-09-12to2022-09-12"> CA </dei:EntityAddressStateOrProvince>

<dei:EntityAddressPostalZipCode contextRef="From2022-09-12to2022-09-12"> 94538 </dei:EntityAddressPostalZipCode>

<dei:CityAreaCode contextRef="From2022-09-12to2022-09-12"> (510) </dei:CityAreaCode>

<dei:LocalPhoneNumber contextRef="From2022-09-12to2022-09-12"> 668-0881 </dei:LocalPhoneNumber>

<dei:WrittenCommunications contextRef="From2022-09-12to2022-09-12"> false </dei:WrittenCommunications>

<dei:SolicitingMaterial contextRef="From2022-09-12to2022-09-12"> false </dei:SolicitingMaterial>

<dei:PreCommencementTenderOffer contextRef="From2022-09-12to2022-09-12"> false </dei:PreCommencementTenderOffer>

<dei:PreCommencementIssuerTenderOffer contextRef="From2022-09-12to2022-09-12"> false </dei:PreCommencementIssuerTenderOffer>

<dei:Security12bTitle contextRef="From2022-09-12to2022-09-12"> Common Stock, par value $0.001 per share </dei:Security12bTitle>

<dei:TradingSymbol contextRef="From2022-09-12to2022-09-12"> ABVC </dei:TradingSymbol>

<dei:SecurityExchangeName contextRef="From2022-09-12to2022-09-12"> NASDAQ </dei:SecurityExchangeName>

<dei:EntityEmergingGrowthCompany contextRef="From2022-09-12to2022-09-12"> false </dei:EntityEmergingGrowthCompany>

</xbrl>

↑Top

Filing Submission 0001213900-22-055465 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Abvc Biopharma, Inc. – ‘8-K’ for 9/12/22 – ‘XML’

On: Tuesday, 9/13/22, at 10:47am ET · For: 9/12/22 · Accession #: 1213900-22-55465 · File #: 1-40700

Previous ‘8-K’: ‘8-K’ on 9/9/22 for 9/4/22 · Next: ‘8-K’ on / for 10/21/22 · Latest: ‘8-K’ on / for 4/19/24

Current Report — Form 8-KFiling Table of Contents

‘XML’ — XBRL Instance — ea165680-8k_abvcbio_htm

This Document is an XBRL XML File.

Current Report — Form 8-K

Filing Table of Contents